- Pimavanserin as an adjunct to an antipsychotic showed significant improvements in the negative symptoms of schizophrenia vs. antipsychotic treatment alone - Pimavanserin well-tolerated among study ...
Kasia Jankiewicz, assistant math professor at UC Santa Cruz, has been awarded a fellowship at the Institute for Advanced Study (IAS) in its School of Mathematics for the 2024-25 academic year. This ...
The Institute for Advanced Study in Princeton, New Jersey, in the United States, is an independent, postdoctoral research center for theoretical research and intellectual inquiry founded in 1930 by ...
Please provide your email address to receive an email when new articles are posted on . A $37 million study led by Newcastle University, University of Edinburgh and Boehringer Ingelheim is underway to ...
Ola Landgren, MD, PhD, shares ADVANCE trial results, which show that adding daratumumab to carfilzomib-lenalidomide-dexamethasone (DKRd) improves outcomes in newly diagnosed multiple myeloma. Landgren ...
About ADVANCE OUTCOMES ADVANCE OUTCOMES is a global, multi-center, placebo-controlled phase 3 study evaluating an extended-release formulation of ralinepag, an oral, selective, potent, once-daily IP ...
A new study suggests some midlife depression symptoms are associated with dementia risk. The study followed nearly 6,000 adults for more than two decades to examine the link. Addressing mental health ...
On Oct. 9, 2023, Harvard economist Claudia Goldin was awarded the Nobel Prize for her work in economics, for creating "the first comprehensive account of women's earnings and labor market ...
Rochester Institute of Technology’s Gabriel Diaz, associate professor in the Chester F. Carlson Center for Imaging Science, has earned the Research to Prevent Blindness/Lions Clubs International ...
Novamigra Therapeutics secures ~€3 million funding to advance first-in-human Phase 1 study of its migraine prophylaxis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results